Granulocyte colony-stimulating factor exacerbates cardiac fibrosis after myocardial infarction in a rat model of permanent occlusion

Cardiovascular Research

Volumn 80, Issue 3, 2008, Pages 425-434

  Cheng, Zhaokang ^a   Ou, Lailiang ^a   Liu, Yi ^a   Liu, Xiaolei ^a   Li, Fei ^b   Sun, Bin ^a   Che, Yongzhe ^c   Kong, Deling ^a   Yu, Yaoting ^a   Steinhoff, Gustav ^d  

^a NANKAI UNIVERSITY   (China)

^b Chinese PLA 254 Hospital   (China)

^c NANKAI UNIVERSITY   (China)

^d UNIVERSITY OF ROSTOCK   (Germany)

Author keywords

Fibrosis; G CSF; Infarct expansion; Myocardial infarction; Remodelling

Indexed keywords

GELATINASE A; GELATINASE B; GRANULOCYTE COLONY STIMULATING FACTOR; MATRIX METALLOPROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

ACUTE HEART INFARCTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY LIGATION; ECHOCARDIOGRAPHY; FEMALE; HEART INFARCTION SIZE; HEART MUSCLE FIBROSIS; HEMODYNAMICS; HISTOPATHOLOGY; LEUKOCYTE COUNT; MONOCYTE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; BLOOD PRESSURE; CORONARY OCCLUSION; DISEASE MODELS, ANIMAL; FEMALE; FIBROSIS; GRANULOCYTE COLONY-STIMULATING FACTOR; HEART VENTRICLES; LEUKOCYTES; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MONOCYTES; MYOCARDIAL INFARCTION; MYOCARDIUM; NEUTROPHILS; RATS; RATS, SPRAGUE-DAWLEY; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TRANSFORMING GROWTH FACTOR BETA; VENTRICULAR REMODELING;

EID: 56549096399     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvn202     Document Type: Article

References (45)

1. Orlic D, Kajstura J, Chimenti S, Jakoniuk I, Anderson SM, Li B et al. Bone marrow cells regenerate infarcted myocardium. Nature 2001;410:701-705.
2. Mangi AA, Noiseux N, Kong D, He H, Rezvani M, Ingwall JS et al. Mesenchymal stem cells modified with Akt prevent remodeling and restore performance of infarcted hearts. Nat Med 2003;9:1195-1201.
3. Fu S, Liesveld J. Mobilization of hematopoietic stem cells. Blood Rev 2000;14:205-218.
4. Kong D, Melo LG, Gnecchi M, Zhang L, Mostoslavsky G, Liew CC et al. Cytokine-induced mobilization of circulating endothelial progenitor cells enhances repair of injured arteries. Circulation 2004;110:2039-2046.
5. Orlic D, Kajstura J, Chimenti S, Limana F, Jakoniuk I, Quaini F et al. Mobilized bone marrow cells repair the infarcted heart, improving function and survival. Proc Natl Acad Sci USA 2001;98:10344-10349.
6. Harada M, Qin Y, Takano H, Minamino T, Zou Y, Toko H et al. G-CSF prevents cardiac remodeling after myocardial infarction by activating the Jak-Stat pathway in cardiomyocytes. Nat Med 2005;11:305-311.
7. Deten A, Volz HC, Clamors S, Leiblein S, Briest W, Marx G et al. Hematopoietic stem cells do not repair the infarcted mouse heart. Cardiovasc Res 2005;65:52-63.
8. Werneck-de-Castro JP, Costa ESRH, de Oliveira PF, Pinho-Ribeiro V, Mello DB, Pecanha R et al. G-CSF does not improve systolic function in a rat model of acute myocardial infarction. Basic Res Cardiol 2006; 101:494-501.
9. Kang HJ, Kim HS, Zhang SY, Park KW, Cho HJ, Koo BK et al. Effects of intracoronary infusion of peripheral blood stem-cells mobilised with granulocyte-colony stimulating factor on left ventricular systolic function and restenosis after coronary stenting in myocardial infarction: the MAGIC cell randomised clinical trial. Lancet 2004;363:751-756.
10. Hill JM, Syed MA, Arai AE, Powell TM, Paul JD, Zalos G et al. Outcomes and risks of granulocyte colony-stimulating factor in patients with coronary artery disease. J Am Coll Cardiol 2005;46:1643-1648.
11. Ince H, Petzsch M, Kleine HD, Schmidt H, Rehders T, Korber T et al. Preservation from left ventricular remodeling by front-integrated revascularization and stem cell liberation in evolving acute myocardial infarction by use of granulocyte-colony-stimulating factor (FIRSTLINE-AMI). Circulation 2005;112:3097-3106.
12. Ripa RS, Jorgensen E, Wang Y, Thune JJ, Nilsson JC, Sondergaard L et al. Stem cell mobilization induced by subcutaneous granulocyte-colony stimulating factor to improve cardiac regeneration after acute ST-elevation myocardial infarction: result of the double-blind, randomized, placebo-controlled stem cells in myocardial infarction (STEMMI) trial. Circulation 2006;113:1983-1992.
13. Zohlnhofer D, Ott I, Mehilli J, Schomig K, Michalk F, Ibrahim T et al. Stem cell mobilization by granulocyte colony-stimulating factor in patients with acute myocardial infarction: a randomized controlled trial. JAMA 2006;295:1003-1010.
14. Engelmann MG, Theiss HD, Hennig-Theiss C, Huber A, Wintersperger BJ, Werle-Ruedinger AE et al. Autologous bone marrow stem cell mobilization induced by granulocyte colony-stimulating factor after subacute ST-segment elevation myocardial infarction undergoing late revascularization: final results from the G-CSF-STEMI (Granulocyte Colony-Stimulating Factor ST-Segment Elevation Myocardial Infarction) trial. J Am Coll Cardiol 2006;48:1712-1721.
15. Sugano Y, Anzai T, Yoshikawa T, Maekawa Y, Kohno T, Mahara K et al. Granulocyte colony-stimulating factor attenuates early ventricular expansion after experimental myocardial infarction. Cardiovasc Res 2005;65:446-456.
16. Vanhoutte D, Schellings M, Pinto Y, Heymans S. Relevance of matrix metalloproteinases and their inhibitors after myocardial infarction: a temporal and spatial window. Cardiovasc Res 2006;69:604-613.
17. Iwanaga Y, Aoyama T, Kihara Y, Onozawa Y, Yoneda T, Sasayama S. Excessive activation of matrix metalloproteinases coincides with left ventricular remodeling during transition from hypertrophy to heart failure in hypertensive rats. J Am Coll Cardiol 2002;39:1384-1391.
18. Li YY, Feldman AM, Sun Y, McTiernan CF. Differential expression of tissue inhibitors of metalloproteinases in the failing human heart. Circulation 1998;98:1728-1734.
19. Petit I, Szyper-Kravitz M, Nagler A, Lahav M, Peled A, Habler L et al. G-CSF induces stem cell mobilization by decreasing bone marrow SDF-1 and up-regulating CXCR4. Nat Immunol 2002;3:687-694.
20. Levesque JP, Hendy J, Takamatsu Y, Simmons PJ, Bendall LJ. Disruption of the CXCR4/CXCL12 chemotactic interaction during hematopoietic stem cell mobilization induced by GCSF or cyclophosphamide. J Clin Invest 2003;111:187-196.
21. Adachi Y, Imagawa J, Suzuki Y, Yogo K, Fukazawa M, Kuromaru O et al. G-CSF treatment increases side population cell infiltration after myocardial infarction in mice. J Mol Cell Cardiol 2004;36:707-710.
22. Fukuhara S, Tomita S, Nakatani T, Ohtsu Y, Ishida M, Yutani C et al. G-CSF promotes bone marrow cells to migrate into infarcted mice heart, and differentiate into cardiomyocytes. Cell Transplant 2004;13:741-748.
23. Dawn B, Guo Y, Rezazadeh A, Huang Y, Stein AB, Hunt G et al. Postinfarct cytokine therapy regenerates cardiac tissue and improves left ventricular function. Circ Res 2006;98:1098-1105.
24. Deindl E, Zaruba MM, Brunner S, Huber B, Mehl U, Assmann G et al. G-CSF administration after myocardial infarction in mice attenuates late ischemic cardiomyopathy by enhanced arteriogenesis. FASEB J 2006;20:956-958.
25. Ohtsuka M, Takano H, Zou Y, Toko H, Akazawa H, Qin Y et al. Cytokine therapy prevents left ventricular remodeling and dysfunction after myocardial infarction through neovascularization. FASEB J 2004;18:851-853.
26. Kanellakis P, Slater NJ, Du XJ, Bobik A, Curtis DJ. Granulocyte colony-stimulating factor and stem cell factor improve endogenous repair after myocardial infarction. Cardiovasc Res 2006;70:117-125.
27. Kuhlmann MT, Kirchhof P, Klocke R, Hasib L, Stypmann J, Fabritz L et al. G-CSF/SCF reduces inducible arrhythmias in the infarcted heart potentially via increased connexin43 expression and arteriogenesis. J Exp Med 2006;203:87-97.
28. Hasegawa H, Takano H, Iwanaga K, Ohtsuka M, Qin Y, Niitsuma Y et al. Cardioprotective effects of granulocyte colony-stimulating factor in swine with chronic myocardial ischemia. J Am Coll Cardiol 2006;47:842-849.
29. Ohki Y, Heissig B, Sato Y, Akiyama H, Zhu Z, Hicklin DJ et al. Granulocyte colony-stimulating factor promotes neovascularization by releasing vascular endothelial growth factor from neutrophils. FASEB J 2005;19:2005-2007.
30. Lee SS, Naqvi TZ, Forrester J, Cattley R, Shah A, Frantzen M et al. The effect of granulocyte colony stimulating factor on regional and global myocardial function in the porcine infarct model. Int J Cardiol 2007;116:225-230.
31. Norol F, Merlet P, Isnard R, Sebillon P, Bonnet N, Cailliot C et al. Influence of mobilized stem cells on myocardial infarct repair in a nonhuman primate model. Blood 2003;102:4361-4368.
32. Terrovitis J, Charitos C, Dolou P, Papalois A, Eleftheriou A, Tsolakis E et al. No effect of stem cell mobilization with GM-CSF on infarct size and left ventricular function in experimental acute myocardial infarction. Basic Res Cardiol 2004;99:241-246.
33. Maekawa Y, Anzai T, Yoshikawa T, Sugano Y, Mahara K, Kohno T et al. Effect of granulocyte-macrophage colony-stimulating factor inducer on left ventricular remodeling after acute myocardial infarction. J Am Coll Cardiol 2004;44:1510-1520.
34. Wheeler JG, Huffine ME, Childress S, Sikes J. Comparison of colony stimulation factors on in vitro rat and human neutrophil function. Biol Neonate 1994;66:214-220.
35. Lehrke S, Mazhari R, Durand DJ, Zheng M, Bedja D, Zimmet JM et al. Aging impairs the beneficial effect of granulocyte colony-stimulating factor and stem cell factor on post-myocardial infarction remodeling. Circ Res 2006;99:553-560.
36. Kuethe F, Figulla HR, Herzau M, Voth M, Fritzenwanger M, Opfermann T et al. Treatment with granulocyte colony-stimulating factor for mobilization of bone marrow cells in patients with acute myocardial infarction. Am Heart J 2005;150:115.
37. Steinwender C, Hofmann R, Kammler J, Kypta A, Pichler R, Maschek W et al. Effects of peripheral blood stem cell mobilization with granulocyte-colony stimulating factor and their transcoronary transplantation after primary stent implantation for acute myocardial infarction. Am Heart J 2006;151:1296.
38. Zbinden S, Zbinden R, Meier P, Windecker S, Seiler C. Safety and efficacy of subcutaneous-only granulocyte-macrophage colony-stimulating factor for collateral growth promotion in patients with coronary artery disease. J Am Coll Cardiol 2005;46:1636-1642.
39. Taguchi A, Wen Z, Myojin K, Yoshihara T, Nakagomi T, Nakayama D et al. Granulocyte colony-stimulating factor has a negative effect on stroke outcome in a murine model. Eur J Neurosci 2007;26:126-133.
40. Deng Z, Yang C, Deng H, Yang A, Geng T, Chen X et al. Effects of GM-CSF on the stem cells mobilization and plasma C-reactive protein levels in patients with acute myocardial infarction. Int J Cardiol 2006;113:92-96.
41. Barron HV, Cannon CP, Murphy SA, Braunwald E, Gibson CM. Association between white blood cell count, epicardial blood flow, myocardial perfusion, and clinical outcomes in the setting of acute myocardial infarction: a thrombolysis in myocardial infarction 10 substudy. Circulation 2000;102:2329- 2334.
42. Matsumura S, Iwanaga S, Mochizuki S, Okamoto H, Ogawa S, Okada Y. Targeted deletion or pharmacological inhibition of MMP-2 prevents cardiac rupture after myocardial infarction in mice. J Clin Invest 2005;115:599-609.
43. Heymans S, Luttun A, Nuyens D, Theilmeier G, Creemers E, Moons L et al. Inhibition of plasminogen activators or matrix metalloproteinases prevents cardiac rupture but impairs therapeutic angiogenesis and causes cardiac failure. Nat Med 1999;5:1135-1142.
44. Minatoguchi S, Takemura G, Chen XH, Wang N, Uno Y, Koda M et al. Acceleration of the healing process and myocardial regeneration may be important as a mechanism of improvement of cardiac function and remodeling by postinfarction granulocyte colony-stimulating factor treatment. Circulation 2004;109:2572-2580.
45. Deten A, Holzl A, Leicht M, Barth W, Zimmer HG. Changes in extracellular matrix and in transforming growth factor beta isoforms after coronary artery ligation in rats. J Mol Cell Cardiol 2001;33:1191-1207.